Find and Pitch Jounalists, Get Your Story Covered

Tags: muscular dystrophy duchenne muscular dystrophy PTC fat weight gain

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - 7 days ago Multiple Sclerosis: Treat Early With High-Efficacy Therapy - about 1 year ago Multiple Sclerosis: Paving the Way to a Cure - about 1 year ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - about 1 year ago
2	Kristen Monaco MedPage Today	Year in Review: Tardive Dyskinesia - 13 days ago Assessing Tardive Dyskinesia Risk - 2 months ago ADHD and Dementia; Alleged Sex Assault in MDMA Trial; iPhones Screen for Depression - about 1 year ago
3	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	The biotech updates you need to read this morning - 24 days ago
4	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies - 24 days ago STAT+: Pfizer’s gene therapy for Duchenne muscular dystrophy fails in Phase 3 trial - 5 months ago STAT+: Avidity Biosciences says its experimental drug showed potential against form of muscular dystrophy - 5 months ago STAT+: Duchenne muscular dystrophy drug from Nippon Shinyaku fails in rare confirmatory trial - 6 months ago STAT+: FDA approves first gene therapy for fatal neuron disease in children - 8 months ago STAT+: Sarepta’s Duchenne gene therapy fails to meet primary endpoint in pivotal trial - about 1 year ago STAT+: What to know about Sarepta’s upcoming data on its Duchenne gene therapy - about 1 year ago
5	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies - 24 days ago STAT+: Sarepta’s Duchenne gene therapy fails to meet primary endpoint in pivotal trial - about 1 year ago
6	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Study Offers Clues for Avoiding RMD Flares After COVID Vaccination - 27 days ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Grants Rare Pediatric Disease Designation to NS-050/NCNP-03 to Treat Muscle Wasting Disease - 2 months ago FDA Grants Rare Pediatric Disease Designation to SAT-3247 to Treat Duchenne Muscular Dystrophy - 3 months ago
8	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia - 3 months ago Givinostat Slows Duchenne Muscular Dystrophy Decline - 7 months ago Obesity Associated With Faster MS Disease Progression - 9 months ago No Change in Huntington's Motor Symptoms With Investigational Drug - 9 months ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Orphan Drug Designation to RAG-18 for Duchenne, Becker Muscular Dystrophy - 3 months ago FDA Approves Givinostat as First Nonsteroidal Drug for Duchenne Muscular Dystrophy - 8 months ago
10	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Researchers Hit the Road to Learn Why CVD and COPD Are Rampant in the Rural South - 3 months ago 'I'm Dying, You're Not': Terminally Ill Ask More States for Physician-Assisted Death - 7 months ago

Journalists covering muscular dystrophy